Shree Ambaji Green Tree Syringe Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 30-06-2024
- Paid Up Capital ₹ 5.00 Cr
as on 30-06-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.10 Cr
as on 30-06-2024
- Satisfied Charges ₹ 14.91 Cr
as on 30-06-2024
- Revenue -91.42%
(FY 2020)
- Profit -172.60%
(FY 2020)
- Ebitda 74.04%
(FY 2020)
- Net Worth -0.12%
(FY 2020)
- Total Assets -0.64%
(FY 2020)
About Shree Ambaji Green Tree Syringe
The Corporate was formerly known as Ambaji Green Tree Syringe Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹21.10 Cr. The company has closed loans amounting to ₹14.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Mehta and Dilip Mehta serve as directors at the Company.
- CIN/LLPIN
U33112WB2001PTC093544
- Company No.
093544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2001
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Ambaji Green Tree Syringe?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashok Mehta | Director | 02-Aug-2001 | Current |
Dilip Mehta | Director | 02-Aug-2001 | Current |
Financial Performance and Corporate Structure Insights of Shree Ambaji Green Tree Syringe.
Shree Ambaji Green Tree Syringe Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 91.42% decrease. The company also saw a substantial fall in profitability, with a 172.6% decrease in profit. The company's net worth dipped by a decrease of 0.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Ambaji Green Tree Syringe?
In 2018, Shree Ambaji Green Tree Syringe had a promoter holding of 58.54% and a public holding of 41.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Edelweiss Asset Reconstruction Company Limited Creation Date: 28 Nov 2006 | ₹21.10 Cr | Open |
State Bank Of India Creation Date: 25 Jun 2012 | ₹1.13 Cr | Satisfied |
Punjab National Bank Creation Date: 30 Jun 2009 | ₹5.15 Cr | Satisfied |
How Many Employees Work at Shree Ambaji Green Tree Syringe?
Unlock and access historical data on people associated with Shree Ambaji Green Tree Syringe, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Ambaji Green Tree Syringe, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Ambaji Green Tree Syringe's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.